Revvity Other Non-Current Liabilities 2010-2024 | RVTY

Revvity other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Revvity other non-current liabilities for the quarter ending September 30, 2024 were $0.846B, a 14.81% decline year-over-year.
  • Revvity other non-current liabilities for 2023 were $0.931B, a 16.07% decline from 2022.
  • Revvity other non-current liabilities for 2022 were $1.109B, a 22.26% decline from 2021.
  • Revvity other non-current liabilities for 2021 were $1.427B, a 84.21% increase from 2020.
Revvity Annual Other Non-Current Liabilities
(Millions of US $)
2023 $931
2022 $1,109
2021 $1,427
2020 $775
2019 $751
2018 $742
2017 $849
2016 $460
2015 $465
2014 $443
2013 $417
2012 $442
2011 $470
2010 $344
2009 $364
Revvity Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-09-30 $846
2024-06-30 $879
2024-03-31 $920
2023-12-31 $931
2023-09-30 $993
2023-06-30 $954
2023-03-31 $1,010
2022-12-31 $1,109
2022-09-30 $1,232
2022-06-30 $1,311
2022-03-31 $1,355
2021-12-31 $1,427
2021-09-30 $1,512
2021-06-30 $839
2021-03-31 $828
2020-12-31 $775
2020-09-30 $721
2020-06-30 $703
2020-03-31 $704
2019-12-31 $751
2019-09-30 $690
2019-06-30 $717
2019-03-31 $689
2018-12-31 $742
2018-09-30 $721
2018-06-30 $744
2018-03-31 $785
2017-12-31 $849
2017-09-30 $496
2017-06-30 $488
2017-03-31 $463
2016-12-31 $460
2016-09-30 $489
2016-06-30 $488
2016-03-31 $487
2015-12-31 $465
2015-09-30 $396
2015-06-30 $401
2015-03-31 $403
2014-12-31 $443
2014-09-30 $398
2014-06-30 $408
2014-03-31 $409
2013-12-31 $417
2013-09-30 $409
2013-06-30 $386
2013-03-31 $381
2012-12-31 $442
2012-09-30 $434
2012-06-30 $417
2012-03-31 $445
2011-12-31 $470
2011-09-30 $431
2011-06-30 $409
2011-03-31 $373
2010-12-31 $344
2010-09-30 $344
2010-06-30 $368
2010-03-31 $369
2009-12-31 $364
2009-09-30 $364
2009-06-30 $347
2009-03-31 $330
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00